= Adobe Acrobat required to view this document.
Get Acrobat here »THE ARTICLES AND RESOURCES
Posted on Mon, Sep 23, 2010
SEER Program of the NCI Provides the Most Accurate Mesothelioma Statistics
The SEER program is the Surveillance, Epidemiology, and End Results program of the National Cancer Institute (NCI). It is the authoritative source of information on cancer incidence and survival in the United States. The NCI is the US government’s lead organization on cancer research.
The SEER Program registries routinely collect data on patient demographics, primary tumor site, tumor morphology and stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data. The mortality data reported by SEER are provided by the National Center for Health Statistics. The population data used in calculating cancer rates is obtained periodically from the Census Bureau. Updated annually and provided as a public service in print and electronic formats, SEER data are used by thousands of researchers, clinicians, public health officials, legislators, policymakers, community groups, and the public.
SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering a quarter of the US population. SEER data includes 23 percent of African Americans, 40 percent of Hispanics, 42 percent of American Indians and Alaska Natives, 53 percent of Asians, and 70 percent of Hawaiian/Pacific Islanders.
For the latest mesothelioma statistical information see the mesothelioma report on the SEER site.
Posted on Fri, Apr 24, 2009
Malignant Mesothelioma Mortality -- United States 1999 - 2005
Posted on Thur, Mar 19, 2008
Dr. William Coley: The Father of Immunotherapy
Posted on Wed, Aug 3, 2007
Mesothelioma Research Update: Dr. Jae Kim explains the link between Meosthelioma and genetic proteins
Written by Dr. Jeni Baker
Posted on Wed, May 30, 2007
Clinical Trials that must be done before a New Drug is allowed for Treatment beyond the Experimental Stage
By Dale E. Wierenga, Ph.D. and C. Robert Eaton
Office of Research and Development Pharmaceutical Manufacturers Association
Alliance Pharmaceutical Corp. --
Posted on Fri, Aug 26, 2005
Fears Confirmed about natural asbestos contamination in Sacramento suburb
By Brian Melley
The Associated Press
El Dorado Hills, Sacramento, CA --
Posted on Mon, July 18, 2005
Natural Asbestos, Cancer linked
By Eric Baily
L.A. Times
Sacramento -- A new study has found that everyday exposure to naturally occurring asbestos boosts the chances of developing a deadly form of cancer...
Posted on Tue, July 14, 2005
Mesothelioma Research Foundation and the Southern California Pipe Trades District Council 16
Jerry and Elizabeth Paul --
SCPTD Council 16 Trade Magazine
Dr. Gill has gotten FDA approval to give Veglin in a shot form (syringe) where you take it home and inject it,...
Posted on Sat, July 9, 2005
Up-Regulation of EphB4 in Mesotheloma and Its Biological Significance
Dr. Parkash S. Gill --
USC Norris Comprehensive Cancer Center
www.aacrjournals.org
Clin Cancer Res 2005;11(12) June 15, 2005
Pg. 4305
Posted on Mon, June 27, 2005
Foundation Newletter
Volume 2, Issue 1
Posted on Tue, October 26, 2004
Reclaiming Living - USC Health Magazine
Alicia Di Rado --
USC Health Magazine
Cancer survivors seek ways beyond drugs to fight cancer recurrence and move on with their lives.
Posted on Tue, October 26, 2004
Eli Lilly Reports European Commission Has Approved Almita For Use In Europe
What Asbestos Exposure Means To You
By Jerry Neil Paul
Attorney
Los Angeles -- Everyone in the Pipetrades and their family should be concerned about asbestos exposure...
Asbestos Exposure: The Truth And What To Do About It
By Jerry Neil Paul
Attorney
Southern and Northern California -- Every trade group is at risk.
Calif. Attorney Starts Meso Research Foundation, Gives $100,000 To Cancer Center
By Steve Vealey
Mealey's Litigation Report: Asbestos
September 21, 2001
Vol. 16, No. 16
Los Angeles -- The foundation seeks to raise research funds through companies and law firms involved in asbestos litigation.
Archive of News Flash Releases
More Coming Soon!
News Flash as of: July 31, 2005
News Flash as of: November 14, 2003
Other Articles of Interest
Nongovernment Group in India Seeks Supreme Court Help To Ban Asbestos
South Africa Set To Implement Ban, Phase Out ASbestos Products
Asbestos Legislation Update
Research Interest in Asbestos-Related Cancer Intensifies
Nine Questions and Answers on Chrysotile and Health
Abstracts Found in Various Medical Journals Concerning Peritoneal Mesothelioma
Asbestos and Cancer - The First Thirty Years
Asbestos and Cancer - The International Lag
Asbestos in Drinking Water and Cancer Incidence in San Francisco
Asbestos Concentration On Marine Vessels
Asbestos in Strange Places: Two Case Reports of Mesothelioma Among Merchant Seamen
Asbestos in the Workplace and the Community
Asbestos-Related Disease in Plumbers and Pipefitters Employed in Building Construction
Malignant Mesothelioma of the pleura: current surgical pathology
Call for an International Ban on Asbestos
Chrysotile Asbestos is the Main Cause of Pleural Mesothelioma
Environmental asbestos exposure and malignant pleural mesothelioma
For questions related to the foundation and to make contributions please contact:
Executive Director
Toll Free:
(800) 909-Meso (6376)
5716 Corsa Avenue, Suite 203
Westlake Village, CA 91362
For more information and other questions contact:
(800) 909-6376
©2010 Mesothelioma Research Foundation Of America